Atlas Trials

Immune Response to Pneumococcal Polysaccharide Vaccine (23-valent) Predicts Asthma Status and Outcomes in Late Adolescents With Asthma

Clinical trial NCT02719379 · COMPLETED

Trial details

NCT number
NCT02719379
Sponsor
Rohit Divekar
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Asthma
Start date
2016-04-01
Primary completion
2017-06-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.